Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
PaperCitations, authors & open-access status
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 118 citations, 2021 year and hybrid oa status.
118
Citations
2021
Year
hybrid
OA Status